S&P 500   3,343.50 (-0.24%)
DOW   27,525.07 (-0.21%)
QQQ   276.80 (-0.14%)
AAPL   114.58 (-0.33%)
MSFT   207.49 (-0.93%)
FB   261.97 (+2.01%)
GOOGL   1,462.30 (+0.25%)
AMZN   3,155.11 (-0.60%)
TSLA   423.36 (+0.51%)
NVDA   535.49 (+2.70%)
BABA   277.08 (+0.39%)
CGC   14.51 (+2.11%)
GE   6.13 (-1.13%)
MU   50.99 (+2.55%)
AMD   82.24 (+3.47%)
T   28.31 (-0.25%)
F   6.62 (-1.05%)
ACB   4.73 (-1.05%)
GILD   62.03 (-1.30%)
NFLX   495.00 (+0.89%)
DIS   125.15 (-0.67%)
BA   164.40 (-1.01%)
BAC   23.83 (-1.08%)
S&P 500   3,343.50 (-0.24%)
DOW   27,525.07 (-0.21%)
QQQ   276.80 (-0.14%)
AAPL   114.58 (-0.33%)
MSFT   207.49 (-0.93%)
FB   261.97 (+2.01%)
GOOGL   1,462.30 (+0.25%)
AMZN   3,155.11 (-0.60%)
TSLA   423.36 (+0.51%)
NVDA   535.49 (+2.70%)
BABA   277.08 (+0.39%)
CGC   14.51 (+2.11%)
GE   6.13 (-1.13%)
MU   50.99 (+2.55%)
AMD   82.24 (+3.47%)
T   28.31 (-0.25%)
F   6.62 (-1.05%)
ACB   4.73 (-1.05%)
GILD   62.03 (-1.30%)
NFLX   495.00 (+0.89%)
DIS   125.15 (-0.67%)
BA   164.40 (-1.01%)
BAC   23.83 (-1.08%)
S&P 500   3,343.50 (-0.24%)
DOW   27,525.07 (-0.21%)
QQQ   276.80 (-0.14%)
AAPL   114.58 (-0.33%)
MSFT   207.49 (-0.93%)
FB   261.97 (+2.01%)
GOOGL   1,462.30 (+0.25%)
AMZN   3,155.11 (-0.60%)
TSLA   423.36 (+0.51%)
NVDA   535.49 (+2.70%)
BABA   277.08 (+0.39%)
CGC   14.51 (+2.11%)
GE   6.13 (-1.13%)
MU   50.99 (+2.55%)
AMD   82.24 (+3.47%)
T   28.31 (-0.25%)
F   6.62 (-1.05%)
ACB   4.73 (-1.05%)
GILD   62.03 (-1.30%)
NFLX   495.00 (+0.89%)
DIS   125.15 (-0.67%)
BA   164.40 (-1.01%)
BAC   23.83 (-1.08%)
S&P 500   3,343.50 (-0.24%)
DOW   27,525.07 (-0.21%)
QQQ   276.80 (-0.14%)
AAPL   114.58 (-0.33%)
MSFT   207.49 (-0.93%)
FB   261.97 (+2.01%)
GOOGL   1,462.30 (+0.25%)
AMZN   3,155.11 (-0.60%)
TSLA   423.36 (+0.51%)
NVDA   535.49 (+2.70%)
BABA   277.08 (+0.39%)
CGC   14.51 (+2.11%)
GE   6.13 (-1.13%)
MU   50.99 (+2.55%)
AMD   82.24 (+3.47%)
T   28.31 (-0.25%)
F   6.62 (-1.05%)
ACB   4.73 (-1.05%)
GILD   62.03 (-1.30%)
NFLX   495.00 (+0.89%)
DIS   125.15 (-0.67%)
BA   164.40 (-1.01%)
BAC   23.83 (-1.08%)
Log in
AMEX:EHC

Encompass Health Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume620,391 shs
Average Volume618,344 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment offers home health services, which include a range of Medicare-certified home nursing services to adult patients, such as skilled nursing, physical, occupational, and speech therapy, as well as medical social work and home health aide services; and hospice services, including in-home services to terminally ill patients and their families, such as pain control and symptom management, as well as provides emotional and spiritual support. As of March 18, 2020, Encompass Health Corporation operated 134 hospitals, 245 home health locations, and 83 hospice locations in 37 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Read More
Encompass Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars


Industry, Sector and Symbol

Industry Medical Care Facilities
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP42192430
Phone+1-205-9677116

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees43,800
Next Earnings Date10/28/2020 (Confirmed)
OptionableOptionable
30 days | 90 days | 365 days | Advanced Chart

Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Encompass Health (AMEX:EHC) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Encompass Health?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 sell rating, 1 hold rating and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Encompass Health
.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Encompass Health
.

How can I listen to Encompass Health's earnings call?

Encompass Health will be holding an earnings conference call on Wednesday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Encompass Health's earnings last quarter?

Encompass Health Corp (AMEX:EHC) announced its quarterly earnings results on Monday, July, 27th. The company reported $0.31 earnings per share for the quarter, missing analysts' consensus estimates of $0.39 by $0.08. The company had revenue of $1.05 billion for the quarter, compared to analysts' expectations of $1.05 billion. Encompass Health's revenue was down 7.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.08 earnings per share.
View Encompass Health's earnings history
.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Wednesday, July 22nd. Stockholders of record on Thursday, October 1st will be given a dividend of $0.28 per share on Thursday, October 15th. This represents a $1.12 annualized dividend and a yield of ∞. The ex-dividend date is Wednesday, September 30th.
View Encompass Health's dividend history
.

What price target have analysts set for EHC?

13 brokerages have issued 1 year price targets for Encompass Health's shares. Their forecasts range from $68.00 to $100.00. On average, they expect Encompass Health's stock price to reach $87.86 in the next twelve months.
View analysts' price targets for Encompass Health
.

Who are some of Encompass Health's key competitors?

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walmart (WMT), Netflix (NFLX), UnitedHealth Group (UNH), Verizon Communications (VZ), AbbVie (ABBV) and Activision Blizzard (ATVI).

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 58, Pay $2.77M)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 58, Pay $1.56M)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 55)
  • Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres of Inpatient Hospitals (Age 54)
  • Ms. April Kaye Bullock Anthony, Chief Exec. Officer of Home Health & Hospice (Age 53, Pay $523.41k)

What is Encompass Health's stock symbol?

Encompass Health trades on the AMEX under the ticker symbol "EHC."

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Encompass Health's official website?

The official website for Encompass Health is www.healthsouth.com.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at +1-205-9677116 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.